Fundz

Emergent Bio Solutions Inc. reported raising $47.9 Million in an initial SEC Form D filing, from an offering of $47.9 Million

PUBLIC · EBSOct 30, 2018

Amount Raised

$47.9 Million

$47.9 Million sold, per SEC Form D (first sale Oct 30, 2018)

Round Type

Venture

GaithersburgManufacturingBiotechnologyHealth Care

Quick answer

Emergent Biosolutions raised $47.9 Million in a funding round, dated October 30, 2018. Emergent Biosolutions is based in Gaithersburg, Maryland, United States.

How much did Emergent Biosolutions raise?
Emergent Biosolutions raised $47.9 Million in a funding round on October 30, 2018.
What does Emergent Biosolutions do?
Emergent Biosolutions is a Maryland-based pharmaceutical company that has sold its sterile manufacturing facility in Camden, Maryland, as part of its restructuring operations.
Where is Emergent Biosolutions based and how big is it?
Emergent Biosolutions is based in Gaithersburg, Maryland, United States. Fundz records about 900 employees.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Emergent Biosolutions that raised within 45 days of this round, from Fundz verified event records.

  • Lifecore Biomedical raised $19M on December 6, 2018.
  • Neochord raised $21M on November 13, 2018.
  • Precision Optics Corporation raised $2M (Seed) on October 29, 2018.
  • Nusano raised $41M on October 24, 2018.
  • ShockWave Medical raised $15M on December 14, 2018.
  • Viracta Therapeutics raised $2M (Seed) on December 13, 2018.

Who to call at Emergent Biosolutions, and when

A new round usually means Emergent Biosolutions is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Emergent Biosolutions raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Emergent Biosolutions, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Emergent Biosolutions. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Emergent Biosolutions

Location

300 Professional Dr

Gaithersburg, Maryland, United States

About

Emergent Biosolutions is a Maryland-based pharmaceutical company that has sold its sterile manufacturing facility in Camden, Maryland, as part of its restructuring operations. The sale of the facility follows the company's announcement of shuttering its Baltimore and Rockville facilities, with plans to save up to $80 million.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Emergent Biosolutions raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Emergent Biosolutions's next move

See what Strategic adds

Emergent Biosolutions raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.